id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2019-N-4203-0033,FDA,FDA-2019-N-4203,"Advisory Committee; Bone, Reproductive and Urologic Drugs Advisory Committee; Renewal",Notice,Advisory Committee,2020-12-11T05:00:00Z,2020,12,2020-12-11T05:00:00Z,,2020-12-11T14:22:38Z,2020-27289,0,0,0900006484998591